1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Artificial Pancreas Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Artificial Pancreas Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Control to Range (CTR) System
1.4.3 Control to Target (CTT) System
1.4.4 Threshold Suspended Device
1.5 Market by Application
1.5.1 Global Artificial Pancreas Systems Market Share by Application: 2021-2026
1.5.2 Diabetes Control to Range (CTR) System
1.5.3 Diabetes Control to Target (CTT) System
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Artificial Pancreas Systems Market
1.8.1 Global Artificial Pancreas Systems Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Artificial Pancreas Systems Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Artificial Pancreas Systems Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Artificial Pancreas Systems Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Artificial Pancreas Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Artificial Pancreas Systems Sales Volume Market Share by Region (2015-2020)
3.2 Global Artificial Pancreas Systems Sales Revenue Market Share by Region (2015-2020)
3.3 North America Artificial Pancreas Systems Sales Volume
3.3.1 North America Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.3.2 North America Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Artificial Pancreas Systems Sales Volume
3.4.1 East Asia Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Artificial Pancreas Systems Sales Volume (2015-2020)
3.5.1 Europe Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Artificial Pancreas Systems Sales Volume (2015-2020)
3.6.1 South Asia Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Artificial Pancreas Systems Sales Volume (2015-2020)
3.7.1 Southeast Asia Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Artificial Pancreas Systems Sales Volume (2015-2020)
3.8.1 Middle East Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Artificial Pancreas Systems Sales Volume (2015-2020)
3.9.1 Africa Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Artificial Pancreas Systems Sales Volume (2015-2020)
3.10.1 Oceania Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Artificial Pancreas Systems Sales Volume (2015-2020)
3.11.1 South America Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.11.2 South America Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Artificial Pancreas Systems Sales Volume (2015-2020)
3.12.1 Rest of the World Artificial Pancreas Systems Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Artificial Pancreas Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Artificial Pancreas Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Artificial Pancreas Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Artificial Pancreas Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Artificial Pancreas Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Artificial Pancreas Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Artificial Pancreas Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Artificial Pancreas Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Artificial Pancreas Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Artificial Pancreas Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Artificial Pancreas Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Artificial Pancreas Systems Sales Volume Market Share by Type (2015-2020)
14.2 Global Artificial Pancreas Systems Sales Revenue Market Share by Type (2015-2020)
14.3 Global Artificial Pancreas Systems Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Artificial Pancreas Systems Consumption Volume by Application (2015-2020)
15.2 Global Artificial Pancreas Systems Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Artificial Pancreas Systems Business
16.1 Medtronic
16.1.1 Medtronic Company Profile
16.1.2 Medtronic Artificial Pancreas Systems Product Specification
16.1.3 Medtronic Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Insulet Corp
16.2.1 Insulet Corp Company Profile
16.2.2 Insulet Corp Artificial Pancreas Systems Product Specification
16.2.3 Insulet Corp Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Pancreum
16.3.1 Pancreum Company Profile
16.3.2 Pancreum Artificial Pancreas Systems Product Specification
16.3.3 Pancreum Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 JDRF
16.4.1 JDRF Company Profile
16.4.2 JDRF Artificial Pancreas Systems Product Specification
16.4.3 JDRF Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Johnson & Johnson
16.5.1 Johnson & Johnson Company Profile
16.5.2 Johnson & Johnson Artificial Pancreas Systems Product Specification
16.5.3 Johnson & Johnson Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Tandem Diabetes Care
16.6.1 Tandem Diabetes Care Company Profile
16.6.2 Tandem Diabetes Care Artificial Pancreas Systems Product Specification
16.6.3 Tandem Diabetes Care Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Dexcom
16.7.1 Dexcom Company Profile
16.7.2 Dexcom Artificial Pancreas Systems Product Specification
16.7.3 Dexcom Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Beta Bionics
16.8.1 Beta Bionics Company Profile
16.8.2 Beta Bionics Artificial Pancreas Systems Product Specification
16.8.3 Beta Bionics Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 TypeZero Technologies
16.9.1 TypeZero Technologies Company Profile
16.9.2 TypeZero Technologies Artificial Pancreas Systems Product Specification
16.9.3 TypeZero Technologies Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Bigfoot Biomedical
16.10.1 Bigfoot Biomedical Company Profile
16.10.2 Bigfoot Biomedical Artificial Pancreas Systems Product Specification
16.10.3 Bigfoot Biomedical Artificial Pancreas Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Artificial Pancreas Systems Manufacturing Cost Analysis
17.1 Artificial Pancreas Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Artificial Pancreas Systems
17.4 Artificial Pancreas Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Artificial Pancreas Systems Distributors List
18.3 Artificial Pancreas Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Artificial Pancreas Systems (2021-2026)
20.2 Global Forecasted Revenue of Artificial Pancreas Systems (2021-2026)
20.3 Global Forecasted Price of Artificial Pancreas Systems (2015-2026)
20.4 Global Forecasted Production of Artificial Pancreas Systems by Region (2021-2026)
20.4.1 North America Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.3 Europe Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.7 Africa Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.9 South America Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Artificial Pancreas Systems Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Artificial Pancreas Systems by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Artificial Pancreas Systems by Country
21.2 East Asia Market Forecasted Consumption of Artificial Pancreas Systems by Country
21.3 Europe Market Forecasted Consumption of Artificial Pancreas Systems by Countriy
21.4 South Asia Forecasted Consumption of Artificial Pancreas Systems by Country
21.5 Southeast Asia Forecasted Consumption of Artificial Pancreas Systems by Country
21.6 Middle East Forecasted Consumption of Artificial Pancreas Systems by Country
21.7 Africa Forecasted Consumption of Artificial Pancreas Systems by Country
21.8 Oceania Forecasted Consumption of Artificial Pancreas Systems by Country
21.9 South America Forecasted Consumption of Artificial Pancreas Systems by Country
21.10 Rest of the world Forecasted Consumption of Artificial Pancreas Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer